Rankings

Market Cap
Revenue
Operating Income
CapEx
Total Assets
Net Assets
Cash on Hand

Sectors

Technology
Healthcare
Financial Services
Consumer Cyclical
Communication Services
Industrials
Consumer Defensive
Energy
Basic Materials
Real Estate
Utilities

Pages

Home
Earnings Calendar
All Sectors
Terms
Privacy

© 2026 Market Cap Arena. All rights reserved.v1.2.30

TBPH Q2 2016 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$700M

Q2 2016 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$5M88.3% margin

Operating Income

-$47M-868.2% margin

Net Income

-$47M-863.2% margin

EPS (Diluted)

$-1.06

QoQ Revenue Growth

-70.3%

Cash Flow

Operating Cash Flow

-$32M

Free Cash Flow

-$33M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$374M

Total Liabilities

$53M

Stockholders' Equity

$322M

Cash & Equivalents

$148M

← FY 2016 All Quarters Q3 2016 →